Microbot Medical Statistics
Total Valuation
MBOT has a market cap or net worth of $124.91 million. The enterprise value is $53.31 million.
| Market Cap | 124.91M |
| Enterprise Value | 53.31M |
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MBOT has 67.16 million shares outstanding. The number of shares has increased by 175.39% in one year.
| Current Share Class | 67.16M |
| Shares Outstanding | 67.16M |
| Shares Change (YoY) | +175.39% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 21.73% |
| Float | 67.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,189.66 |
| Forward PS | 23.13 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 507.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.59, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.59 |
| Quick Ratio | 21.44 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.58% and return on invested capital (ROIC) is -19.26%.
| Return on Equity (ROE) | -27.58% |
| Return on Assets (ROA) | -18.40% |
| Return on Invested Capital (ROIC) | -19.26% |
| Return on Capital Employed (ROCE) | -21.48% |
| Weighted Average Cost of Capital (WACC) | 9.86% |
| Revenue Per Employee | $2,442 |
| Profits Per Employee | -$330,512 |
| Employee Count | 43 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.14% in the last 52 weeks. The beta is 1.03, so MBOT's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -23.14% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 2.36 |
| Relative Strength Index (RSI) | 46.56 |
| Average Volume (20 Days) | 1,363,285 |
Short Selling Information
The latest short interest is 7.64 million, so 11.38% of the outstanding shares have been sold short.
| Short Interest | 7.64M |
| Short Previous Month | 7.68M |
| Short % of Shares Out | 11.38% |
| Short % of Float | 11.38% |
| Short Ratio (days to cover) | 3.86 |
Income Statement
In the last 12 months, MBOT had revenue of $105,000 and -$14.21 million in losses. Loss per share was -$0.26.
| Revenue | 105,000 |
| Gross Profit | 2,000 |
| Operating Income | -16.04M |
| Pretax Income | -14.21M |
| Net Income | -14.21M |
| EBITDA | -16.00M |
| EBIT | -16.04M |
| Loss Per Share | -$0.26 |
Balance Sheet
The company has $72.50 million in cash and $898,000 in debt, with a net cash position of $71.60 million or $1.07 per share.
| Cash & Cash Equivalents | 72.50M |
| Total Debt | 898,000 |
| Net Cash | 71.60M |
| Net Cash Per Share | $1.07 |
| Equity (Book Value) | 74.11M |
| Book Value Per Share | 1.10 |
| Working Capital | 73.14M |
Cash Flow
In the last 12 months, operating cash flow was -$15.23 million and capital expenditures -$155,000, giving a free cash flow of -$15.38 million.
| Operating Cash Flow | -15.23M |
| Capital Expenditures | -155,000 |
| Depreciation & Amortization | 44,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -15.38M |
| FCF Per Share | -$0.23 |
Margins
| Gross Margin | 1.90% |
| Operating Margin | -15,278.10% |
| Pretax Margin | -13,535.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -175.39% |
| Shareholder Yield | -175.39% |
| Earnings Yield | -11.38% |
| FCF Yield | -12.31% |
Analyst Forecast
The average price target for MBOT is $7.00, which is 276.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 276.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2018. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 5, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |